An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

A Study of Zomacton in Children With Growth Hormone Deficiency

NCT00884000 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency

NCT02173821 ·Status: COMPLETED ·Phase: PHASE3

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ·Status: COMPLETED ·Phase: PHASE3

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

NCT05723835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children

NCT00452491 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Growth Hormone in Very Young Girls With Turner Syndrome

NCT00406926 ·Status: COMPLETED ·Phase: PHASE3

Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

NCT00625872 ·Status: TERMINATED ·Phase: PHASE3

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

NCT01734447 ·Status: COMPLETED ·Phase: PHASE4

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

NCT05330325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature

NCT06927310 ·Status: RECRUITING ·Phase: PHASE3

Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age

NCT00174252 ·Status: COMPLETED ·Phase: PHASE3

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NCT01073605 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

NCT00184691 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Children With Insufficient Secretion of Growth Hormone

NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT01592500 ·Status: COMPLETED ·Phase: PHASE2

Drug Use Investigation of Somatropin for GHD-ADULTS.

NCT00601419 ·Status: COMPLETED

Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

NCT00174408 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

NCT07226089 ·Status: RECRUITING ·Phase: PHASE3

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

NCT01066052 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

NCT00174291 ·Status: TERMINATED ·Phase: PHASE3

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

NCT07221851 ·Status: RECRUITING ·Phase: PHASE3